Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00614913 · ClinicalTrials.gov registry record · Phase 1

Proton Beam Therapy for Treatment of Hepatocellular Carcinoma

A Phase 1 study, sponsored by Loma Linda University.

Completed
Registry status
Phase 1
Development phase
76
Enrollment target

NCT00614913: Completed Phase 1 study, sponsored by Loma Linda University.

NCT00614913 is a Phase 1 study that has completed, run by Loma Linda University. The registered enrollment target is 76 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (27% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00614913, a Phase 1 study, has completed, sponsored by Loma Linda University.

COMPLETED
Registry status
Phase 1
Development phase
76 participants
Enrollment target

Study Summary

This study is designed to evaluate the possible benefits and side effects of the use of proton therapy for patients with hepatocellular carcinoma.

Primary Outcome

Percent of participants alive and without tumor progression 3 years following treatment.

Interventions

  • RADIATION Proton radiation therapy

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 1998-05
Est. Completion 2009-02
Phase Phase 1
Loma Linda University

237 total trials

What the finished NCT00614913 record still lists

NCT00614913 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (27% higher).

The record links to 0 conditions, and to 1 intervention - of which Proton radiation therapy is the first listed.

NCT00614913 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00614913 about?

NCT00614913 is a clinical study titled "Proton Beam Therapy for Treatment of Hepatocellular Carcinoma". This study is designed to evaluate the possible benefits and side effects of the use of proton therapy for patients with hepatocellular carcinoma.

What is the current status of trial NCT00614913?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 76 participants. The study started on 1998-05. Estimated completion is 2009-02.

What interventions are being tested in trial NCT00614913?

The interventions under investigation include: Proton radiation therapy (RADIATION).

Who is sponsoring clinical trial NCT00614913?

This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00614913's enrollment target sits among peer trials

76 705th of 2000 higher than 1,290 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02615184 · 76 participants · Phase 2

    A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old

  • NCT02821741 · 76 participants · NA

    Effects of External Ear Stimulation on Pain Perception and Mood

  • NCT03019757 · 76 participants

    Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

  • NCT03353584 · 76 participants · NA

    Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00614913, the US trial registry maintained by the National Library of Medicine. NCT00614913 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.